Drug‐Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC‐122) in Healthy Adult Subjects - Ogasawara, Ken; MacGorman, Kimberly; Liu, Liangang; Chen, Jian; Carayannopoulos, Leonidas N.; Zhou, Simon; Palmisano, Maria; Li, Yan (Journal of clinical pharmacology, 2019)
Keywords: avadomide; CYP1A2; CYP3A; drug‐drug interactions; immunomodulatory drug; CYP3A; drug-drug interactions; avadomide; CYP1A2; immunomodulatory drug